The largest database of trusted experimental protocols

3 protocols using cd56 bv480

1

Detection of SARS-CoV-2-specific B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To detect SARS-CoV-2-specific B cells, we conjugated recombinant RBD proteins with Alexa Fluor 488 or Alexa Fluor 594 (Thermo Fisher Scientific) according to the manufacturer’s protocol. Approximately 10 × 106 frozen PBMC from 13 convalescent donors were prepared in Falcon® 5ml-round bottom polystyrene tubes at a final concentration of 14 × 106 cells/mL in RPMI 1640 medium (GIBCO) supplemented with 10% of fetal bovine serum (Seradigm), Penicillin- Streptomycin (GIBCO) and HEPES (GIBCO). After a rest of 2h at 37°C and 5% CO2, cells were stained using Aquavivid viability marker (GIBCO) in DPBS (GIBCO) at 4°C for 20min. The detection of SARS-CoV-2-antigen specific B cells was done by adding the RBD probes to the following antibody cocktail: IgM BUV737, CD24 BUV805, IgG BV421, CD3 BV480, CD56 BV480, CD14 BV480, CD16 BV480, CD20 BV711, CD21 BV786, HLA DR BB700, CD27 APC R700 all from BD Biosciences; CD19 BV650 from Biolegend and IgA PE from Miltenyi. Staining was performed at 4°C for 30min and cells were fixed using 2% paraformaldehyde at 4°C for 15min. Stained PBMC samples were acquired on Symphony cytometer (BD Biosciences) and analyzed using FlowJo v10.7.1 (TreeStar). In each experiment, PBMC from unexposed donors (total of n = 9) were included to ensure consistent specificity of the assay.
+ Open protocol
+ Expand
2

Detecting SARS-CoV-2-Specific B Cells in PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To detect SARS-CoV-2-specific B cells, we conjugated recombinant RBD proteins with Alexa Fluor 488 or Alexa Fluor 594 (Thermo Fisher Scientific) according to the manufacturer’s protocol. Approximately 107 frozen PBMCs from 12 convalescent donors were prepared at a final concentration of 14 × 106 cells/mL in RPMI 1640 medium (GIBCO) supplemented with 10% of fetal bovine serum (VWR, Radnor, PA, USA), Penicillin-Streptomycin (GIBCO) and HEPES (GIBCO). After a rest of 2 h at 37 °C and 5% CO2, cells were stained using Aquavivid viability marker (GIBCO) in DPBS (GIBCO) at 4 °C for 20 min. The detection of SARS-CoV-2-antigen specific B cells was accomplished by adding the RBD probes to the following antibody cocktail: IgM BUV737, IgG BV421, CD3 BV480, CD56 BV480, CD14 BV480, CD16 BV480, and CD20 BV711, all from BD Biosciences, Franklin Lakes, NJ, USA and CD19 BV650 from Biolegend, San Diego, CA, USA. Staining was performed at 4 °C for 30 min and cells were fixed using 2% paraformaldehyde at 4 °C for 15 min. Stained PBMC samples were acquired with a Symphony cytometer (BD Biosciences) and analyzed using FlowJo v10.7.1 (TreeStar, Woodburn, OR, USA). The gating strategy is shown in Figure S2.
+ Open protocol
+ Expand
3

Multiparameter Flow Cytometry Analysis of Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
For analysis of surface markers, fresh PBMCs were incubated for 30 min at room temperature in Stain Buffer (BD Biosciences) with optimal concentrations of the fluorochrome conjugated antibodies. Lymphocyte subsets were determined using the monoclonal antibodies as follows: CD3 APCH7 (Clone-SK-7), CD4 BV480 (Clone -SK-3), CD8 FITC (Clone-RPA-T8), CD62L APC (Clone-Dreg 56), CCR7 PE (Clone-2-L1-A), CD45RA BV421 (Clone-5H9), CD56 BV480 (Clone-NCAM 16.2), and CD16 FITC (Clone-3G8) (BD Biosciences). The cells were further washed with Stain Buffer, fixed with 1% formaldehyde in PBS and acquired to obtain 100,000 gated lymphocyte events on FACS Jazz (BD Biosciences). Gating strategy for identification of different immune cells and subsets was depicted in Supporting Information Material 1. The data was analyzed using FACS Flow Jo software V10.7 (BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!